Data / Form D filings / Mnemosyne Pharmaceuticals Inc
Mnemosyne Pharmaceuticals Inc: Form D filings
Mnemosyne Pharmaceuticals Inc, a biotechnology company in Providence, RI, filed 4 Form D notices with the SEC between 2012 and 2015. The latest, on February 4, 2015, reports $12.3 million sold of a $13 million offering to 6 investors.
Find out what Mnemosyne Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- THREE DAVOL SQUARE, SUITE A425, Providence, RI, 02903
- Phone
- (401) 632-0383
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1542171
The full lists. Form D filings in Rhode Island: 60 rows, $5, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 4, 2015 | Amendment | $12,952,680 | $12,332,334 | $620,346 | 6 | Feb 1, 2012 | sec.gov |
| Jul 3, 2013 | Amendment | $11,384,496 | $8,384,496 | $3,000,000 | 6 | Feb 1, 2012 | sec.gov |
| Feb 1, 2013 | Amendment | $5,384,496 | $3,234,496 | $2,150,000 | 4 | Feb 1, 2012 | sec.gov |
| Feb 16, 2012 | New notice | $5,384,496 | $3,234,496 | $2,150,000 | 4 | Feb 1, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Bristol | Director | |
| Frank Menniti | Executive Officer | |
| Richard Horan | Director | |
| Peter Barrett | Director | |
| Vanessa King | Executive Officer, Director | |
| William Koster | Director |
Every Form D from the week of Feb 2, 2015 · All recent filings in Rhode Island · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mnemosyne Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.